Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Preferred Shares (2021 - 2025)

BioRestorative Therapies (BRTX) has disclosed Preferred Shares for 5 consecutive years, with $13982.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Preferred Shares changed 0.0% year-over-year to $13982.0, compared with a TTM value of $13982.0 through Sep 2025, changed 0.0%, and an annual FY2024 reading of $13982.0, changed 0.0% over the prior year.
  • Preferred Shares was $13982.0 for Q3 2025 at BioRestorative Therapies, roughly flat from $13982.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $15432.0 in Q4 2021 and bottomed at $13982.0 in Q2 2023.
  • Average Preferred Shares over 5 years is $14494.5, with a median of $13982.0 recorded in 2023.
  • The sharpest move saw Preferred Shares decreased 9.4% in 2023, then changed 0.0% in 2024.
  • Year by year, Preferred Shares stood at $15432.0 in 2021, then fell by 1.62% to $15182.0 in 2022, then dropped by 7.9% to $13982.0 in 2023, then changed by 0.0% to $13982.0 in 2024, then changed by 0.0% to $13982.0 in 2025.
  • Business Quant data shows Preferred Shares for BRTX at $13982.0 in Q3 2025, $13982.0 in Q2 2025, and $13982.0 in Q1 2025.